FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

GDUFA Research Supports Generic Drug Development

The FDA FY 2021 GDUFA Science and Research Outcomes Report demonstrates how GDUFA research projects have contributed to the development of generic dru...

latest-news-card-1
Human Drugs

FDA, C-Path Exploring Lysosomal Diseases Group

FDA says it is partnering with the Critical Path Institute to explore creating a Lysosomal Diseases Consortium as part of the Accelerating Rare Diseas...

latest-news-card-1
Medical Devices

eCential Robotics Bone Surgical System Cleared

FDA clears an eCential Robotics 510(k) for its 3D imaging, navigation and robotics guidance system for use in bone surgical procedures.

latest-news-card-1
Medical Devices

Respironics Troubles Broaden as it Pays $24 Mil. Over False Claims

As it negotiates a consent decree over its ventilators and other airway devices with the Department of Justice (DoJ), the company agrees to settle Fal...

latest-news-card-1
Medical Devices

Integra CereLink Monitor Recall is Class 1

FDA says the Integra recall of 388 CereLink intracranial pressure monitors is Class 1.

latest-news-card-1
Federal Register

Oncologic Drugs Panel to Review Y-mAbs BLA

Federal Register notice: FDA announces a 10/28 Oncologic Drugs Advisory Committee meeting.

latest-news-card-1
Federal Register

Panel to Vote on SolvD Genetic Test

Federal Register notice: FDA announces a 10/20 advisory committee meeting that will vote on a SolvD test to identify opioid use disorder at-risk patie...

latest-news-card-1
FDA General

FDAs Whole-of-Government Approach to Illicit Products

FDA officials say the agency is taking a whole-of-governments approach to combating the entry of illicit healthcare products into the U.S.

Medical Devices

FDA Clears Viz.ai Algorithm

FDA clears a Viz.ai algorithm to give the ratio between right and left ventricle diameters in a patients heart for use in pulmonary embolism treatment...

latest-news-card-1
Human Drugs

Former Pharmatech CEO Gets 37 Months in Jail

A Florida federal judge sentenced the former CEO of Pharmatech to 37 months in federal prison after he pled guilty to several charges of lying to and ...